The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
RDP Pharma AG, a Swiss biotechnology company focused on next-generation protein degradation therapeutics, and the Experi...
Portal Biotech, a pioneering biotechnology company headquartered in London, has secured $35 million in Series A funding,...
Swedish biotech firm Sprint Bioscience has entered a research collaboration with the Experimental Drug Development Cen...
Scientists at the National University of Singapore (NUS Medicine)'s Yong Loo Lin School of Medicine have found proteins ...
A new lab-grown material has revealed that some of the effects of ageing in the heart may be slowed and even reversed. T...
A research team led by Dr Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in collaboration w...
A research team led by Associate Professor Yoshinori Yoshida and Specially Appointed Assistant Professor Yuya ...
Fujirebio, a leading innovator in in-vitro diagnostics, has announced a collaboration with Stanford Medicine, ...
Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering products, s...
The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development,...
Taxis Pharmaceuticals, a US-based clinical stage company at the forefront of developing therapies to treat multidrug-res...
Taiwan’s National Biotechnology Research Park (NBRP) hosted the 2025 Antibody Therapeutic & Frontiers in Biome...
XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. announced that the National Medical Product Administration (NM...
Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) and Antimicrobial ...
Alloy Therapeutics Inc., a US-based biotechnology ecosystem company, has recently opened its first location in Japa...
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...
Patients with non-proliferative diabetic retinopathy (NPDR) currently face a therapeutic gap—one that often leaves...
